Contact this trialFirst, we need to learn more about you.
RXC007 for Idiopathic Pulmonary Fibrosis
Recruiting0 awardsPhase 2
Houston, Texas
This trial tests RXC007, a new drug, for safety and side effects in patients with Idiopathic Pulmonary Fibrosis (IPF). Researchers will measure the drug levels in the blood and its impact on disease markers.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service